Merck & Co., Inc.'s Fosamax: Is Long Term Use of Bone Strengthening Drug Linked to Fractures?

Examiner -- Fosamax, a popular osteoporosis medication for which nearly 40 million prescriptions have been written, may be putting some at risk for spontaneous femur fractures. Fosamax is part of a group of drugs called bisphosphonates designed to make bones stronger.

MORE ON THIS TOPIC